Tracleer continues to fuel Actelion growth
February 19, 2010Sales and Marketing Actelion, Tracleer
Actelion has posted a 20% increase in revenue on the strength of its pulmonary hypertension treatment Tracleer. The drug saw …
Rituxan gains approval for most common leukaemia
February 19, 2010Sales and Marketing FDA, MabThera, Rituxan, blood cancer
Roche’s blockbuster cancer treatment MabThera/Rituxan has been approved by the FDA for the treatment of adult leukaemia. The drug earned …
Clinipace appoints Bud Owen and Daryl Porter
February 19, 2010Research and Development Clinipace, appointment, research and development
CRO and eClinical technology specialist Clinipace Worldwide has appointed Bud Owen as its chief financial officer, while Daryl Porter has …
Dr Jay Feingold joins Daiichi Sankyo
February 19, 2010Research and Development Daiichi Sankyo, appointment, research and development
Daiichi Sankyo’s US arm has appointed Dr Jay Feingold vice president of medical affairs. In this role his will manage …
Plans for more home care on NHS could save billions
February 18, 2010NHS, home care
The NHS is to provide more dialysis and chemotherapy at home as part of a government bid to move treatment …
Québec supports $38m Galderma investment
February 18, 2010Manufacturing and Production Canada, Galderma, Quebec, biopharmaceutical
The regional government in Québec in Canada is to contribute 10% of the costs of a new investment in manufacturing …
Merck’s HIV treatment fails in phase III
February 18, 2010Research and Development HIV, Merck
Merck’s HIV treatment vicriviroc has disappointed in phase III trials, and may be dropped by the company. The results failed …
Hospital criticised for profiting from medicines trade
February 18, 2010Manufacturing and Production parallel trade, supply chain
An NHS hospital has been heavily criticised for trading in medicines to make a profit. It has emerged that the …
Harlequin Solutions appoints marketing manager Sandrine Desmares-Vaury
February 18, 2010Medical Communications Harlequin Solutions, appointment, medical communications
Guildford, UK-based online design consultancy Harlequin Solutions has appointed Sandrine Desmares-Vaury as marketing manager. “I am delighted to be joining …
Drug development: where’s the added investment value?
February 18, 2010Research and Development CRO, Les Rose, R&D, biotech, funding
Venture capital is a curious business. The global financial crisis which we are slowly emerging from has exposed some rather …
Wyeth’s Dr Graham Cook joins British Pharmacopoeia Commission
February 18, 2010Research and Development, Sales and Marketing Wyeth Pharmaceuticals, appointment, research and development, sales and marketing
Dr Graham Cook, a senior director in the Global Quality and Compliance division of Wyeth Pharmaceuticals, has joined the British …
Chiltern Opens New Office In Argentina
February 17, 2010Research and Development
Oscar Podesta, Chiltern Executive Director, Latin America, leads this endeavor. “Our office, strategically located in suburban Pilar, is a natural …
PolyTherics raises £3m to fund PEG expansion
February 17, 2010Manufacturing and Production, Research and Development PolyTherics, biotech, pegylation
UK drug delivery specialist PolyTherics has raised an additional £3 million in funding as it extends the focus of its …
BASF boosts spray-drying capacity with GEA Niro alliance
February 17, 2010Manufacturing and Production BASF, spray-drying
The custom synthesis division of chemicals giant BASF has joined forces with processing equipment specialist GEA Niro to broaden its …
Merger boosts Merck’s revenue
February 17, 2010Sales and Marketing MA, Merck
Merck’s merger with Schering-Plough in October has helped boost the company’s full year sales by 13% to $27.4 billion.The gain …
AstraZeneca signs deal with Rigel on RA treatment
February 17, 2010Research and Development AZ, Rigel, rheumatoid arthritis
AstraZeneca is looking to enter the lucrative rheumatoid arthritis market by in-licensing a phase II treatment.The global market for rheumatoid …
Dr Steven Leventer to head up neuroscience research for PharmaNet
February 17, 2010Research and Development PharmaNet, appointment, research and development
PharmaNet Development Group has named Dr Steven Leventer to the position of vice president, clinical research – neuroscience. Leventer joins …
Obituary – Cephalon’s Paul Jewsbury
February 17, 2010Medical Communications, Sales and Marketing Cephalon, appointment, medical communications, sales and marketing
Cephalon UK’s senior product manager Paul Jewsbury lost his long and hard-fought battle against a recurring brain tumour in December.Paul, …
Immatics vaccine trials to be conducted with Cancer Research UK
February 16, 2010Research and Development immatics, vaccines
Cancer Research Technology, the development and commercial arm of Cancer Research UK, has reached an agreement to collaborate with German-based …
Abbott completes Solvay acquisition
February 16, 2010Sales and Marketing Abbott, Solvay
Abbott has completed its $6.2 billion acquisition of Solvay’s pharma division.The acquisition is expected to add $2.9 billion to Abbott’s …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
